⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 17, 2026
Investdesk

NSE

Marksans Pharma LimitedMARKSANS

Marksans Pharma Limited is an Indian pharmaceutical company focused on manufacturing and marketing of generic drugs.

Key productsGeneric drugs, APIs (Active Pharmaceutical Ingredients)
GeographyIndia, Export markets in Southeast Asia, Middle East
CompetitorsDr Reddy's Laboratories, Cipla

AI-generated overview — verify before relying on it.

Net institutional flow

+₹371.1 Cr

Institutional buyers

8 in / 0 out

High-impact filings

1 · tilt Bullish

Next corporate action

Dividend - Re 0.80 Per Share

ex 2025-08-01

Competitive landscape — the read

vs most-traded names · ALL
1M3M6M1Y2YAll
Institutional money is backing ATALREAL hardest (+₹7.2 Cr net). MARKSANS ranks #4 of 7 on flow (net buying +₹0 Cr). Filing momentum favours MARKSANS (+1).
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1ATALREAL+₹7.2 Cr154————
2MOBIKWIK+₹0.1 Cr83————
3QUADFUTURE+₹0 Cr134————
4MARKSANSThis——1+1——
5MTNL+₹0 Cr2————
6GATECH+₹0 Cr8————
7IRMENERGY−₹2.2 Cr328————

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — MARKSANS day by day

1M3M6M1Y2YAll
  1. 2026-06-16FilingMarksans Pharma Limited has informed the Exchange about Update on acquisition of QliniQ B.V.M&A
  2. 2026-06-09FilingMarksans Pharma Limited has informed the Exchange that India Ratings and Research has revised the outlook forRating
  3. 2026-06-08FilingMarksans Pharma Limited has informed the Exchange about Schedule for Virtual Investor ConferenceInvestor Call
  4. 2025-08-01ActionDividend - Re 0.80 Per ShareDividend
  5. 2025-06-11BulkSELL · ₹256.8 CrORBIMED ASIA IV MAURITIUS FVCI LIMITED
  6. 2025-06-11BulkBUY · ₹75 CrUNIFI BLEND FUND 2
  7. 2025-06-11BulkBUY · ₹81.2 CrUNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLI
  8. 2025-06-11BlockBUY · ₹15 CrBANDHAN MUTUAL FUND
  9. 2025-06-11BlockBUY · ₹10 CrCITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED
  10. 2025-06-11BlockSELL · ₹256.8 CrORBIMED ASIA IV MAURITIUS FVCI LIMITED
  11. 2025-06-11BlockBUY · ₹23 CrSOCIETE GENERALE
  12. 2025-06-11BlockBUY · ₹13.4 CrSUBHKAM VENTURES I PRIVATE LIMITED
  13. 2025-06-11BlockBUY · ₹14 CrUNIFI BCAD FUND
  14. 2025-06-11BlockBUY · ₹75 CrUNIFI BLEND FUND 2
  15. 2025-06-11BlockBUY · ₹14.8 CrUNIFI CAPITAL PRIVATE LIMITED
  16. 2025-06-11BlockBUY · ₹81.2 CrUNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLI
  17. 2025-06-11BlockBUY · ₹10.4 CrUTI MUTUAL FUND
  18. 2025-06-11NetDay net −₹100.6 Cr
  19. 2024-09-20BulkSELL · ₹74.8 CrGRAVITON RESEARCH CAPITAL LLP
  20. 2024-09-20BulkBUY · ₹74.8 CrGRAVITON RESEARCH CAPITAL LLP
  21. 2024-09-20BulkSELL · ₹107.9 CrUBS PRINCIPAL CAPITAL ASIA LIMITED
  22. 2024-09-20BulkBUY · ₹72.9 CrVANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
  23. 2024-09-20BulkBUY · ₹85.5 CrVANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
  24. 2024-09-20NetDay net +₹50.5 Cr
  25. 2024-09-17ActionDividend - Rs 0.60 Per ShareDividend

Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.

Filings that matter

  • 7
    M&ABullish

    Acquisition update suggests growth strategy, positive for MARKSANS.

    Source PDF →
  • 2
    RatingNeutral

    India Ratings and Research has revised the outlook for the Company s bank loan facilities to Positive from Stable

    Source PDF →
  • 2
    Investor CallNeutral

    Schedule for Virtual Investor Conference

    Source PDF →

Bulk & block deals

1M3M6M1Y2YAll

18 deals · 2024-09-20 → 2025-06-11

DateCounterpartyTypeSideValue
2025-06-11ORBIMED ASIA IV MAURITIUS FVCI LIMITEDHNI / otherSELL₹256.8 Cr
2025-06-11UNIFI BLEND FUND 2InstitutionBUY₹75 Cr
2025-06-11UNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLIHNI / otherBUY₹81.2 Cr
2025-06-11BANDHAN MUTUAL FUNDInstitutionBUY₹15 Cr
2025-06-11CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITEDInstitutionBUY₹10 Cr
2025-06-11ORBIMED ASIA IV MAURITIUS FVCI LIMITEDHNI / otherSELL₹256.8 Cr
2025-06-11SOCIETE GENERALEHNI / otherBUY₹23 Cr
2025-06-11SUBHKAM VENTURES I PRIVATE LIMITEDInstitutionBUY₹13.4 Cr
2025-06-11UNIFI BCAD FUNDInstitutionBUY₹14 Cr
2025-06-11UNIFI BLEND FUND 2InstitutionBUY₹75 Cr

18 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.

Results & transcripts

Financial results

None yet.

News & chatter on MARKSANS

RSS News

0

No recent news.

Google News RSS — links open the source.

Investdesk

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.